Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20091
20112
20121
20141
20171
20182
20191
20203
20211
20222
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting5
Active, not recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group4
AbbVie2
Amgen2
AstraZeneca2
Merck Sharp & Dohme LLC2
pharmaand GmbH2
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms24
Ovarian Neoplasms19
Carcinoma, Ovarian Epithelial11
Peritoneal Neoplasms5
Neoplasms2
Adenocarcinoma, Clear Cell1
Brenner Tumor1
Genital Diseases, Female1
Neoplasm Metastasis1
Ovarian Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.